Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.428.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.459NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.415.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.98NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.566NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.480NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.579NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.11 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.435NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.124NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.384NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XAQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.569NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.524NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.596.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.473NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.76.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.494NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-22948.2US
B.1.167NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-13863.4US
B.1.267NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.165NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.554NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.450NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.130NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.444NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.103NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.485NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.119NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.276NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.111NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.336NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used